Skip header and navigation

2 records – page 1 of 1.

Cardiovascular OCT Imaging

https://libcat.nshealth.ca/en/permalink/provcat33952
Ik-Kyung Jang, editor. --Cham, Switzerland: Springer , c2015.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Other Authors
Jang, Ik-Kyung
Responsibility
Ik-Kyung Jang, editor
Alternate Title
Cardiovascular Optical Coherence Tomography Imaging
Place of Publication
Cham, Switzerland
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xi, 222 pages)
ISBN
9783319108018 (electronic bk.)
9783319108001
Subjects (MeSH)
Acute Coronary Syndrome - diagnosis
Coronary Artery Disease - diagnosis
Endovascular Procedures
Tomography, Optical Coherence
Subjects (LCSH)
Cardiovascular system - Tomography
Cardiovascular system - Diseases - Tomography
Optical coherence tomography
Contents
1. The Development of OCT -- 2. Physics of Cardiovascular OCT -- 3. Histology Validation of OCT Images -- 4. Basic Interpretation Skills -- 5. Intravascular OCT Imaging Artifacts -- 6. Clinical Presentations and Coronary Plaque Characteristics -- 7. Insight into Pathogenesis of Acute Coronary Syndrome -- 8. Spontaneous Coronary Artery Dissection -- 9. Early Stent Evaluation -- 10. Late Stent Change -- 11. Stent Thrombosis -- 12. Neoatherosclerosis -- 13. Bioabsorbable Stent -- 14. Consensus Documents -- 15. Future Development.
Format
e-Book
Location
Online
Less detail
Nova Scotia Health Authority. QEII. Cardiology. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1496
Available Online
View Pamphlet
Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Cardiology
Alternate Title
Brilinta
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Platelet Aggregation Inhibitors - therapeutic use
Adenosine - therapeutic use
Cardiovascular Diseases - prevention & control
Myocardial Infarction - prevention & control
Pulmonary Embolism - prevention & control
Subjects (LCSH)
Adenosine
Anticoagulants (Medicine)
Cardiovascular system--Diseases--Prevention
Myocardial infarction--Prevention
Abstract
Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
Responsibility
Prepared by: Cardiology
Pamphlet Number
1496
Less detail